APA

Nayak S. U., Griffiss J. M., McKenzie R., Fuchs E. J., Jurao R. A., An A. T., Ahene A., Tomic M., Hendrix C. W. & Zenilman J. M. (20150909). Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A. : Antimicrobial agents and chemotherapy.

Chicago

Nayak S U, Griffiss J M, McKenzie R, Fuchs E J, Jurao R A, An A T, Ahene A, Tomic M, Hendrix C W and Zenilman J M. 20150909. Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A. : Antimicrobial agents and chemotherapy.

Harvard

Nayak S. U., Griffiss J. M., McKenzie R., Fuchs E. J., Jurao R. A., An A. T., Ahene A., Tomic M., Hendrix C. W. and Zenilman J. M. (20150909). Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A. : Antimicrobial agents and chemotherapy.

MLA

Nayak S U, Griffiss J M, McKenzie R, Fuchs E J, Jurao R A, An A T, Ahene A, Tomic M, Hendrix C W and Zenilman J M. Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A. : Antimicrobial agents and chemotherapy. 20150909.